Myron Shulgan KC
Fortuna: 2 M $ al 31/07/2026
Fortuna: 2 M $ al 31/07/2026
Mr. Myron W.
Shulgan KC is an Independent Director at Drugs Made In America Acquisition II Corp.
and an Independent Director at Drugs Made In America Acquisition Corp.
He is on the Board of Directors at Drugs Made In America Acquisition II Corp.
and Drugs Made In America Acquisition Corp.
Mr. Shulgan KC was previously employed as a Partner by Sutts, Strosberg LLP.
He received his undergraduate degree from the University of Windsor and a graduate degree from the University of Windsor.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
0,41 % | 15/04/2026 | 100.000 ( 0,41 % ) | 1 M $ | 31/07/2026 |
0,16 % | 26/09/2025 | 100.000 ( 0,16 % ) | 1 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|
| Empresas | Cargo | Fin |
|---|---|---|
Sutts, Strosberg LLP
Sutts, Strosberg LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
University of Windsor
University of Windsor Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sutts, Strosberg LLP
Sutts, Strosberg LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.